Angiogenic factor-based signature predicts prognosis and immunotherapy response in non-small-cell lung cancer

HIGHLIGHTS

  • who: Predicts Prognosis and collaborators from the Department of Human Anatomy, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China have published the Article: Angiogenic Factor-Based Signature Predicts Prognosis and Immunotherapy Response in Non-Small-Cell Lung Cancer, in the Journal: (JOURNAL)
  • what: The Kaplan-Meier plot showed that the samples in the high-risk group had a worse prognosis with a p-value and amp;lt; 0.05, which indicated that the model had high accuracy. differed significantly across the different tumor stages and TNM stages, which was consistent with . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?